Amarin Corp Plc (AMRN)

[Whalatane]

gg. NVS is not buying any biotech that’s lost their US patent . Why would they ?.
Since NVS is Swiss based there was probably a deal that could have been done re distribution of V with NVS’s existing EU sales team / infrastructure .

They obviously couldn’t come to terms with AMRN if there was any negotiations so we are now left with the cash burn associated with trying to launch there

Scripts have roughly gone sideways .. so far .. this year in the US … correct ?
Be interesting to see how much AMRN spent on sales reps and marketing to achieve that .

Kiwi